Quarterly report pursuant to Section 13 or 15(d)

WARRANTS (Details Narrative)

WARRANTS (Details Narrative) - USD ($)				3 Months Ended		9 Months Ended
WARRANTS (Details Narrative) - USD ($)	Mar. 06, 2024	Jun. 01, 2023	Jul. 28, 2020	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Oct. 16, 2020	Jan. 26, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number				389,369		389,369
Debt face amount				$ 0		$ 0		$ 16,304,000
Cash Proceeds									$ 0
Share-based Payment Arrangement, Tranche One [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Debt face amount			$ 20,000,000
CFF Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares										33,334
Exercise price of warrants										$ 396
Investment Agreement [Member] \| CFF Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares				36,207		36,207
Exercise price of warrants				$ 381.14		$ 381.14
Weighted average remaining life of warrants						9 months 3 days
Warrant expire date				Jan. 26, 2025		Jan. 26, 2025
Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants to purchase shares of common stock, exercised	142,857	194,444	2,873
Exercise price of warrants			$ 208.8
Loan Agreement [Member] \| K2 Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants to purchase shares of common stock, exercised			2,873
Warrants outstanding to purchase of common stock shares			2,873
Exercise price of warrants			$ 208.8
Warrant expire date			Jul. 28, 2030
Professional Services Agreement [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Issuance of common stock, net of issuance costs, shares				4,649	0	4,649	0
Professional Services Agreement [Member] \| Warrants [Member] \| Investor Relations Service Provider [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares									14,000
Exercise price of warrants									$ 32.1
Warrant expire date									Nov. 03, 2025
Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Issuance of common stock, net of issuance costs, shares				6,087		6,087
Warrants to purchase shares of common stock, exercised					0		0